Enteric Disease Testing Market
Enteric Disease Testing Market Size, Share & Trends Analysis Report, By Pathogen Tested (E. coli, Salmonella, Campylobacter, and Listeria), By Technology (Traditional, Rapid, Polymerase chain reaction (PCR), Immunoassay, and Chromatography & Spectrometry), By End-User (Water and Food), Forecast Period (2022-2028)
Enteric disease testing market is anticipated to grow at a CAGR of 3.2% during the forecast period. Enteric diseases are caused by micro-organisms such as bacteria, viruses, and parasites that cause intestinal illness. These are caused mainly by consuming contaminated food or water or by contact with animals or their environments. The rising incidence of enteric diseases across the globe is resulting increasing demand for enteric disease testing. For instance, according to World Health Organisation (WHO), each year around 1.3 to 4 million peoples gets cholera and around 21,000 to 143,000 peoples die due to cholera across the globe, it is an acute diarrhoeal disease that can kill within hours if left untreated. This shows the increasing number of enteric diseases across the globe, which in turn, contributes to the growth of the global enteric disease testing market.
Segmental Outlook
The global enteric disease testing market is segmented based on pathogen tested, technology and end-user. Based on the pathogen tested, the market is segmented into E. coli, salmonella, campylobacter, and listeria. Based on technology, the market is segmented into the traditional, rapid, polymerase chain reaction (PCR), immunoassay, chromatography & spectrometry. Based on end-use, the market is segmented into water and food. The above-mentioned segments can be customized as per the requirements. Based on technology the rapid technology is anticipated to hold a significant share in the global enteric disease testing market during the forecast period. Rapid technology is mainly used in food technology to monitor the type, count, and metabolites of organisms that lead to the preservation, food spoilage, fermentation, safety, and foodborne pathogens.
Salmonella Segment to Witness Significant Share in the Global Enteric Disease Testing Market During the Forecast Period.
Based on pathogen tested, salmonella segment is anticipated to hold a potential share in the global enteric disease testing market across the globe. Salmonella is one of the most common types of food poisoning caused by bacteria, which causes stomach cramps and diarrhea and affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool. People get infected through contaminated water or food and mostly food is the main source of this illness. According to the Centers for Disease Control and Control And Prevention (CDC) report that Salmonella bacteria cause about 1.35 million infections, 26,500 hospitalizations, and 420 mortalities in the US every year. Hence, enteric disease testing for further treatment of the condition.
Regional Outlook
The global enteric disease testing market is further segmented based on geography including North America (the US and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North American region is anticipated to hold a significant share in the global enteric diseases testing market owing to the presence of key players, such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and others that provides advanced testing for the early detection of diseases and provide proper treatment. Asia-Pacific is anticipated to hold potential share in the global enteric disease testing market during the forecast period. The rising prevalence of cholera and rising awareness regarding such disorders is primarily contributing to the market growth in the region. The three largest cholera endemic countries across the globe include India, China, and Indonesia. This, in turn, is driving the demand for enteric disease testing in the region.
Global Enteric Disease Testing Market Growth, by Region 2022-2028
Market Players Outlook
The major companies serving the global enteric disease testing market include Bio-Rad Laboratories, Inc., Abbott Laboratories, Quest Diagnostics, BioMerieux SA, and Meridian Bioscience, Inc. The market players are contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and new product launches, to stay competitive in the market. For instance, in April 2022, SGS SA upgraded its food testing laboratory in Callao city, Peru. Now the laboratory will support in critical food testing services with a turnaround time that is 50-70% quicker than that of its previous one. The new laboratory conduct tests on fishmeal, oily fish and fish oils, dairy products, meat, processed food products, vegetables (fresh, dehydrated, and frozen), and others.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global enteric disease testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Recovery Scenario of Global Enteric Disease Testing Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Bio-Rad Laboratories, Inc.
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Abbott Laboratories
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Quest Diagnostics
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Biomerieux SA
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. Meridian Bioscience Inc.
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Enteric Disease Testing Market by Pathogen Tested
4.1.1. E. coli
4.1.2. Salmonella
4.1.3. Campylobacter
4.1.4. Listeria
4.1.5. Others
4.2. Global Enteric Disease Testing Market by Technology
4.2.1. Traditional
4.2.2. Rapid
4.2.3. Polymerase chain reaction (PCR)
4.2.4. Immunoassay
4.2.5. Chromatography & spectrometry
4.3. Global Enteric Disease Testing Market by End User
4.3.1. Water
4.3.2. Food
4.3.2.1. Meat, Poultry, and Seafood
4.3.2.2. Dairy Products
4.3.2.3. Processed Food
4.3.2.4. Fruits & Vegetables
4.3.2.5. Other Food Products (Nuts, Herbs & Spices, and Cereals & Grains)
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AsureQuality Ltd.
6.2. Becton, Dickinson and Company (BD)
6.3. Bio-Rad Laboratories, Inc.
6.4. Certified Laboratories Inc.
6.5. Coris BioConcept SPRL
6.6. Eurofins Scientific
6.7. Hardy Diagnostics
6.8. Intertek Group plc
6.9. Merck Group (Merck KGaA)
6.10. Mérieux NutriSciences Corp
6.11. Neogen Corp
6.12. Nova Biologicals
6.13. PerkinElmer, Inc.
6.14. Quest Diagnostics
6.15. Romer Labs Division Holding GmbH
6.16. SGS SA
6.17. Symbio Laboratories
6.18. TÜV SÜD
1. GLOBAL ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY PATHOGEN TESTED, 2021-2028 ($ MILLION)
2. GLOBAL ENTERIC DISEASE TESTING FOR E. COLI MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ENTERIC DISEASE TESTING FOR SALMONELLA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ENTERIC DISEASE TESTING FOR CAMPYLOBACTER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL ENTERIC DISEASE TESTING FOR LISTERIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
7. GLOBAL ENTERIC DISEASE TESTING BY TRADITIONAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL ENTERIC DISEASE TESTING BY RAPID MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL ENTERIC DISEASE TESTING BY POLYMERASE CHAIN REACTION (PCR) MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL ENTERIC DISEASE TESTING BY IMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL ENTERIC DISEASE TESTING BY CHROMATOGRAPHY & SPECTROMETRY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY END-USE, 2021-2028 ($ MILLION)
13. GLOBAL ENTERIC DISEASE TESTING FOR WATER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL ENTERIC DISEASE TESTING FOR FOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY PATHOGEN TESTED, 2021-2028 ($ MILLION)
18. NORTH AMERICAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY END-USE, 2021-2028 ($ MILLION)
20. EUROPEAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. EUROPEAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY PATHOGEN TESTED, 2021-2028 ($ MILLION)
22. EUROPEAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
23. EUROPEAN ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY PATHOGEN TESTED, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY END-USE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. REST OF THE WORLD ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY PATHOGEN TESTED, 2021-2028 ($ MILLION)
30. REST OF THE WORLD ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
31. REST OF THE WORLD ENTERIC DISEASE TESTING MARKET RESEARCH AND ANALYSIS BY END-USE, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ENTERIC DISEASE TESTING MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ENTERIC DISEASE TESTING MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ENTERIC DISEASE TESTING MARKET, 2021-2028 (%)
4. GLOBAL ENTERIC DISEASE TESTING MARKET SHARE BY PATHOGEN TESTED, 2021 VS 2028 (%)
5. GLOBAL ENTERIC DISEASE TESTING FOR E. COLI MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ENTERIC DISEASE TESTING FOR SALMONELLA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL ENTERIC DISEASE TESTING FOR CAMPYLOBACTER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL ENTERIC DISEASE TESTING FOR LISTERIA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL ENTERIC DISEASE TESTING MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
10. GLOBAL ENTERIC DISEASE TESTING BY TRADITIONAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL ENTERIC DISEASE TESTING BY RAPID MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL ENTERIC DISEASE TESTING BY POLYMERASE CHAIN REACTION (PCR) MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL ENTERIC DISEASE TESTING BY IMMUNOASSAY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL ENTERIC DISEASE TESTING BY CHROMATOGRAPHY & SPECTROMETRY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL ENTERIC DISEASE TESTING MARKET SHARE BY END-USE, 2021 VS 2028 (%)
16. GLOBAL ENTERIC DISEASE TESTING FOR WATER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL ENTERIC DISEASE TESTING FOR FOOD MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL ENTERIC DISEASE TESTING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. US ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
20. CANADA ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
21. UK ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
22. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
23. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
24. ITALY ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
25. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF EUROPE ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
27. INDIA ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
28. CHINA ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
29. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
30. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD ENTERIC DISEASE TESTING MARKET SIZE, 2021-2028 ($ MILLION)
